Journal of Thrombosis and Thrombolysis

, Volume 35, Issue 2, pp 271–278

Percutaneous coronary intervention in patients with haemophilia presenting with acute coronary syndrome: an interventional dilemma: case series, review of the literature, and tips for management

  • Paul Fefer
  • Sharon Gannot
  • Aaron Lubetsky
  • Uri Martinowitz
  • Shlomi Matetzky
  • Victor Guetta
  • Amit Segev
Article

Abstract

Since the introduction of clotting factor concentrates over 50 years ago the life expectancy of patients with hemophilia (PWH) has increased to over 70 years. Consequently, diseases of the ageing population, including coronary artery disease, are increasingly being encountered. These patients present a unique therapeutic problem due to their greatly increased bleeding risk. Randomized controlled studies specific to PWH are lacking, emphasizing the need for case series. We present three cases of acute coronary syndrome in PWH who underwent urgent percutaneous coronary intervention at our institution, and summarize the available literature on the topic. We describe their management and outcome and provide points to consider when treating these complex patients.

Keywords

Haemophilia Acute coronary syndrome Percutaneous coronary angioplasty Coagulation factors Anticoagulation Anti-platelets 

References

  1. 1.
    Mejia-Carvajal C, Czapek EE, Valentino LA (2006) Life expectancy in hemophilia outcome. J Thromb Haemost 4(3):361–368CrossRefGoogle Scholar
  2. 2.
    Darby SC, Kan SW, Spooner RJ, Giagrande PL, Hill FG, Hay CR, Lee CA, Ludlam CA, Williams M (2007) Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood 110(3):815–825PubMedCrossRefGoogle Scholar
  3. 3.
    Plug I, Van Der Bom JG, Peters M, Mauser-Bunscoten EP, De Goede-Bolder A, Heijnen L, Smit C, Willemse J, Rosendaal FR (2006) Mortality and cases of death in patients with hemophilia, 1992–2001: a prospective cohort study. J Thromb Haemost 4(3):510–516PubMedCrossRefGoogle Scholar
  4. 4.
    Franchini M, Tagliaferri A, Mannucci PM (2007) The management of hemophilia in elderly patients. Clin Interv Aging 2(3):261–268Google Scholar
  5. 5.
    Girolami A, Ruzzon E, Fabris F, Varvarikis C, Sartori R, Girolami B (2006) Myocardial infarction and other arterial occlusions in hemophilia A patients. A cardiological evaluation of all 42 cases reported in the literature. Acta Haematol 116(2):120–125PubMedCrossRefGoogle Scholar
  6. 6.
    Alsolaiman MM, Chang K, Arjoman H, Oza R, Costacurta G (2000) Acute left anterior descending artery occlusion in a hemophiliac A patient during recombinant factor VIII infusion: treatment with coronary angioplasty. Catheter Cardiovasc Interv 50(4):468–472PubMedCrossRefGoogle Scholar
  7. 7.
    Wright RS, Anderson JL, Adams CD, Bridges CR, DE Casey Jr, Ettinger SM, Fesmire FM, Ganiats TG, Jneid H, Lincoff AM, Peterson ED, Philippides GJ, Theroux P, Wenger NK, Zidar JP, Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, DE Casey Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Theroux P, Wenger NK, Zidar JP, American college of cardiology foundation/American heart association task force on practice guidelines (2011) 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. J Am Coll Cardiol 57(19):e215–e367PubMedCrossRefGoogle Scholar
  8. 8.
    Task force on myocardial revascularization of the European society of cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS), European association for percutaneous cardiovascular interventions (EAPCI), Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D (2010) Guidelines on myocardial revascularization. Eur Heart J 31:2501–2555PubMedCrossRefGoogle Scholar
  9. 9.
    Vogel B, Hahne S, Kozanli I, Kalla K, Jarai R, Freynhofer M, Smetana P, Nurnberg M, Geppert A, Unger G, Huber K (2011) Influence of updated guidelines of short- and long-term mortality in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS). Int J Cardiol. doi:10.1016/j.ijcard.2011.02.073 Google Scholar
  10. 10.
    Furie B, Furie BC (1998) The molecular basis of blood coagulation. Cell 53:505–518CrossRefGoogle Scholar
  11. 11.
    Furie B, Furie BC (1992) Molecular and cell biology of blood coagulation. N Engl J Med 326(12):800–806PubMedCrossRefGoogle Scholar
  12. 12.
    White GC 2nd, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J, Factor VIII and factor IX subcommittee (2001) Definitions in hemophilia, recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the international society on thrombosis and haemostasis. Thromb Haemost 85:560PubMedGoogle Scholar
  13. 13.
    Hoenig MR, Aroney CN, Scott IA (2010) Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent era. Cochrane Database Syst Rev (3):CD004815Google Scholar
  14. 14.
    Segev A, Strauss BH, Tan M, Constance C, Langer A, Goodman SG, Canadian acute coronary syndromes registries investigators (2005) Predictors and 1-year outcome of major bleeding in patients with non-ST-elevation acute coronary syndromes: insights from the Canadian acute coronary syndrome registries. Am Heart J 150(4):690–694PubMedCrossRefGoogle Scholar
  15. 15.
    Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S (2006) Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 114(8):774–782PubMedCrossRefGoogle Scholar
  16. 16.
    Rao SV, Eikelboom JA, Granger CB, Harrington RA, Califf RM, Bassand JP (2007) Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J 7(4):225–233Google Scholar
  17. 17.
    Chase AJ, Fretz EB, Warburton WP, Klinke WP, Carere RG, Pi D, Berry B, Hilton JD (2008) Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L. study (mortality benefit of reduced transfusion after percutaneous coronary intervention via the arm or leg). Heart 94:1019–1025PubMedCrossRefGoogle Scholar
  18. 18.
    Stone GW, White HD, Ohman EM, Bertrand ME, Lincoff AM, McLaurin BT, Cox DA, Pocock SJ, Ware JH, Feit F, Colombo A, Manoukian SV, Lansky AJ, Mehran R, Moses JW, Acute catheterization and urgent intervention triage strategy (ACUITY) trial investigators (2007) Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the acute catheterization and urgent intervention triage strategy (ACUITY) trial. Lancet 369(9565):907–919PubMedCrossRefGoogle Scholar
  19. 19.
    Montalescot G, Ongen Z, Guindy R, Sousa A, Lu SZ, Pahlajani D, Pellois A, Vicaut E, RIVIERA investigators (2007) Predictors of outcome in patients undergoing PCI. Results of the RIVIERA study. Int J Cardiol 129:379–387PubMedCrossRefGoogle Scholar
  20. 20.
    Schutgens RE, Tuinenburg A, Roosendaal G, Guyomi SH, Mauser-Bunschoten EP (2009) Treatment if ischaemic heart disease in haemophilia patients: an institutional guideline. Haemophilia 15(4):952–958PubMedCrossRefGoogle Scholar
  21. 21.
    Jolly SS, Yusuf S, Cairns J, Niemelä K, Xavier D, Widimsky P, Budaj A, Niemelä M, Valentin V, Lewis BS, Avezum A, Steg PG, Rao SV, Gao P, Afzal R, Joyner CD, Chrolavicius S, Mehta SR, RIVAL trial group (2011) Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomized, parallel group, multicentre trial. Lancet 377(9775):1409–1420PubMedCrossRefGoogle Scholar
  22. 22.
    Virtanen R, Kauppila M, Itala M (2004) Percutaneous coronary intervention with stenting in a patient with haemophilia A and an acute myocardial infarction following a single dose of desmopressin. Thromb Haemost 92(5):1154–1156PubMedGoogle Scholar
  23. 23.
    Windecker S, Simon R, Lins M, Klauss V, Eberli FR, Roffi M, Pedrazzini G, Moccetti T, Wenaweser P, Togni M, Tuller D, Zbinden R, Seiler C, Mehilli J, Kastrati A, Meier B, Hess OM (2005) Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization: the TiNOX trial. Circulation 111(20):2617–2622PubMedCrossRefGoogle Scholar
  24. 24.
    Leone AM, Sgueglia GA, Porto I, Niccoli G, Burzotta F, Trani C, De Caterina AR, Buffon A, Mazzari MA, Mongiardo R, Rebuzzi AG, Crea F (2010) The heart study: a real-world experience using the CID chrono carbostent in primary and rescue PCI. J Cardiovasc Med (Hagerstown). doi:10.2459/JCM.0b013e32834102d8 Google Scholar
  25. 25.
    Klomp M, Beijk MA, Damman P, Woudstra P, Koch KT, Tijssen JG, de Winter RJ (2011) Three-year clinical follow-up of an unselected patient population treated with the genous endothelial progenitor cell capturing stent. J Interv Cardiol 24(5):442–449PubMedCrossRefGoogle Scholar
  26. 26.
    Petrillo G, Cirillo P, Leosco D, Maresca F, Piscione F, Chiariello M (2011) Percutaneous coronary intervention in a patient with acute non-ST-elevation myocardial infarction and haemophilia A: a ‘genous’ experience. Haemophilia 17:e239–e247CrossRefGoogle Scholar
  27. 27.
    Krolick MA (2005) Successful percutaneous coronary intervention in a patient with severe haemophilia A using bivalirudin as the sole procedural anticoagulant. Haemophilia 11(4):415–417PubMedCrossRefGoogle Scholar
  28. 28.
    Valgimigli M, Campo G, Monti M, Vranckx P, Percoco G, Tumscitz C, Castriota F, Colombo F, Tebaldi M, Fucà G, Kubbajeh M, Cangiano E, Minarelli M, Scalone A, Cavazza C, Frangione A, Borghesi M, Marchesini J, Parrinello G, Ferrari R, Prolonging dual antiplatelet treatment after grading stent-induced intimal hyperplasia study (PRODIGY) investigators (2012) Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial. Circulation 125(16):2015–2026PubMedCrossRefGoogle Scholar
  29. 29.
    Rittger H, Brachmann J, Sinha AM, Waliszewski M, Ohlow M, Brugger A, Thiele H, Birkemeyer R, Kurowski V, Breithardt OA, Schmidt M, Zimmermann S, Lonke S, von Cranach M, Nguyen TV, Daniel WG, Wöhrle J (2012) A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. J Am Coll Cardiol 59(15):1377–1382PubMedCrossRefGoogle Scholar
  30. 30.
    Ferguson JJ, Califf RM, Antman EM, Cohen M, Grines CL, Goodman S, Kereiakes DJ, Langer A, Mahaffey KW, Nessel CC, Armstrong PW, Avezum A, Aylward P, Becker RC, Biasucci L, Borzak S, Col J, Frey MJ, Fry E, Gulba DC, Guneri S, Gurfinkel E, Harrington R, Hochman JS, Kleiman NS, Leon MB, Lopez-Sendon JL, Pepine CJ, Ruzyllo W, Steinhubl SR, Teirstein PS, Toro-Figueroa L, White H, SYNERGY trial investigators (2004) Enoxaparin vs unfractionated heparin in high risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY trial. JAMA 292(1):45–54PubMedCrossRefGoogle Scholar
  31. 31.
    Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG (1995) Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 332(20):1330–1335PubMedCrossRefGoogle Scholar
  32. 32.
    Mamas MA, Ratib K, Routledge H, Fath-Ordoubadi F, Neyses L, Louvard Y, Fraser DG, Nolan J (2012) Influence of access site selection on PCI-related adverse events in patients with STEMI: meta-analysis of randomised controlled trials. Heart 98(4):303–311PubMedCrossRefGoogle Scholar
  33. 33.
    Yan BP, Ajani AE, Clark DJ, Duffy SJ, Andrianopoulos N, Brennan AL, Loane P, Reid CM (2011) Recent trends in Australian percutaneous coronary intervention practice: insights from the Melbourne interventional group registry. Med J Aust 195(3):122–127PubMedGoogle Scholar
  34. 34.
    Hemophilia of Georgia, U.S.A.(2012) Protocols for the treatment of haemophilia and von Willebrand disease. http://www.hog.org
  35. 35.
    Forman MB, Kopelman HA, Gleaton JH, Janco RL, Perry JM (1986) Percutaneous transluminal angioplasty in hemophilia. Am Heart J 111(1):169–172PubMedCrossRefGoogle Scholar
  36. 36.
    Helft G, Metzger JP, Samama MM, Rothschild C, Batisse JP, Vacheron A (1997) Coronary stenting in a hemophiliac patient. Thromb Haemost 77(5):1044–1045PubMedGoogle Scholar
  37. 37.
    Peerlinck K, Vermylen J (1999) Acute myocardial infarction following administration of recombinant activated factor VII (novo seven) in a patient the haemophilia A and inhibitor. Thromb Haemost 82(6):1775–1776PubMedGoogle Scholar
  38. 38.
    MacKinlay N, Taper J, Renisson F, Rickard K (2000) Cardiac surgery and catheterization in patients with haemophilia. Haemophilia 6(2):84–88PubMedCrossRefGoogle Scholar
  39. 39.
    Au WY, Jim MH, Lam CC (2002) Unusual case of coronary artery disease in a patient with severe hemophilia B. Am J Hematol 69(2):152–153PubMedCrossRefGoogle Scholar
  40. 40.
    Bovenzi F, De Luca L, Signore N, Fusco F, De Luca I (2003) Abciximab for the treatment of an acute thrombotic coronary occlusion during stent implantation in a patient with severe hemophilia B. Ital Heart J 4(10):728–730PubMedGoogle Scholar
  41. 41.
    Arora UK, Dhir M, Cintron G, Strom JA (2004) Successful multi-vessel percutaneous coronary intervention with bivalirudin in a patient with severe hemophilia A: a case report and review of literature. J Invasive Cardiol 16(6):330–332PubMedGoogle Scholar
  42. 42.
    Kerkhoffs JL, Atsma DE, Oemrawsingh PV, Eikenbloom J, Van der Meer FJM (2004) Acute myocardial infarction during substitution with recombinant factor VIII concentrate in a patient with mild haemophilia A. Thromb Haemost 92(2):425–426PubMedGoogle Scholar
  43. 43.
    Ferrario C, Renders F, Cairoli A, Vuffray A, Spertini O, Angelillo-Scherrer A (2007) Management of an acute coronary syndrome in a patient with severe haemophilia A. Haemophilia 13(6):763–765PubMedCrossRefGoogle Scholar
  44. 44.
    Smolka G, Kulach A, Dabek J, Szulc A, Gasior Z (2007) Percutaneous coronary intervention with stent implantation in haemophiliac A patient with unstable angina. Haemophilia 13(4):428–431PubMedCrossRefGoogle Scholar
  45. 45.
    Quintero D, Biria M, Meyers DG (2008) Percutaneous coronary intervention in a patient with acute ST-elevation myocardial infarction and hemophilia A. J Invasive Cardiol 20(5):240–241PubMedGoogle Scholar
  46. 46.
    Pesaro AE, Gaz MV, Karbstein R, Perin M, Serrano CV, Damico E (2009) Coronary artery bypass surgery, angioplasty and long term anti-platelet treatment in a type B hemophilia patient. Clinics (Sao Paulo) 64(8):822–823CrossRefGoogle Scholar
  47. 47.
    Kim DK, Kim DI, Kim MS, Lee EJ, Kim YB, Cho HJ, Han YC, Kim U, Seol SH, Yang TH, Kim DK, Kim DS (2010) Successful percutaneous coronary intervention for acute coronary syndrome in a patient with severe hemophilia A. Korean Circ J 40:527–529PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Paul Fefer
    • 1
  • Sharon Gannot
    • 1
  • Aaron Lubetsky
    • 2
  • Uri Martinowitz
    • 2
  • Shlomi Matetzky
    • 1
  • Victor Guetta
    • 1
  • Amit Segev
    • 1
  1. 1.Leviev Heart CenterSheba Medical Center and Tel Aviv UniversityTel HashomerIsrael
  2. 2.The National Hemophilia CenterSheba Medical Center and Tel Aviv UniversityTel HashomerIsrael

Personalised recommendations